US Panel Issues New Guidance On Prostate Cancer Screening
A US government advisory panel has reversed its opposition to a controversial prostate cancer screening test for men aged 55 to 69, according to draft recommendations published Tuesday in the Journal of the American Medical Association. Patients are now advised to discuss the potential benefits and harms of prostate-specific antigen (PSA)-based screening with their physicians … Read more